Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Treasury Shares (2021 - 2025)

Exagen (XGN) has disclosed Treasury Shares for 5 consecutive years, with $1.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Treasury Shares rose 4.99% year-over-year to $1.8 million, compared with a TTM value of $1.8 million through Dec 2025, up 4.99%, and an annual FY2025 reading of $1.8 million, up 4.99% over the prior year.
  • Treasury Shares was $1.8 million for Q4 2025 at Exagen, up from $1.8 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $1.8 million in Q1 2025 and bottomed at $185000.0 in Q1 2021.
  • Average Treasury Shares over 5 years is $1.2 million, with a median of $1.5 million recorded in 2023.
  • The sharpest move saw Treasury Shares skyrocketed 374.91% in 2022, then dropped 2.52% in 2025.
  • Year by year, Treasury Shares stood at $415325.0 in 2021, then soared by 149.49% to $1.0 million in 2022, then soared by 33.9% to $1.4 million in 2023, then grew by 23.27% to $1.7 million in 2024, then grew by 4.99% to $1.8 million in 2025.
  • Business Quant data shows Treasury Shares for XGN at $1.8 million in Q4 2025, $1.8 million in Q3 2025, and $1.7 million in Q2 2025.